Giraudo Bryan 4
4 · Protagonist Therapeutics, Inc · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Giraudo Bryan
Director
Transactions
- Award
Common Stock
2025-01-02+5,130→ 15,130 total - Award
Stock Option (right to buy)
2025-01-02+6,584→ 6,584 totalExercise: $38.98Exp: 2035-01-02→ Common Stock (6,584 underlying)
Holdings
- 8,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents grant of restricted stock units payable solely in common stock that will vest in full on January 15, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date.
- [F2]The stock option vests in 12 equal monthly installments following January 2, 2025, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.